Home | All intervention

[RDF data]
Intervention #100033 (Drug:oral erlotinib and pulsed doses of oral AT-101)

Resource URI: http://static.linkedct.org/resource/intervention/100033
PropertyValue
linkedct:description Patients will receive oral erlotinib 100 mg daily and pulsed doses of oral AT-101 given 40 mg twice daily on days 1-3 of a 21-day cycle. If the initial combination of erlotinib and AT-101 is tolerated, dose escalation of erlotinib to 150 mg daily will be allowed at the discretion of the treating investigator at the start of cycle 2. Patients will continue receiving treatment on study until they refuse further therapy, develop evidence of progressive disease, or develop unacceptable toxicity or a medical condition that would, in the judgment of the investigator,
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00988169>
linkedct:intervention_id 100033 (xsd:int)
linkedct:intervention_name oral erlotinib and pulsed doses of oral AT-101
linkedct:intervention_type Drug
rdfs:label Intervention #100033 (Drug:oral erlotinib and pulsed doses of oral AT-101)
rdf:type linkedct:intervention